NovaBay’s DERMADoctors Products Introduced to Millions of Households in QVC® Placement

Biopharmaceutical skincare company, NovaBay Pharmaceuticals (NYSE American: NBY) has made its third appearance on vCommerce leader, QVC.

NovaBay Chief Product Officer, Dr. Audrey Kunin, joined Girls Night In with Courtney & Jane to introduce DERMADoctor’s Calm Cool + Corrected eczema and dermatitis clinical repair balm to millions of households across the United States. The segment was an overwhelming success.

Highlights

  • NovaBay’s DERMADoctor Calm Cool + Corrected clinical repair balm was marketed to QVC’s national audience;
  • The feature is NovaBay’s third appearance on QVC and a new opportunity to leverage QVC’s television and digital platforms to increase brand recognition;
  • Eczema, or atopic dermatitis, is a chronic, inflammatory skin disease, affects an estimated 31 million Americans;
  • The atopic dermatitis market is expected to reach $22.6 billion by 2031.

NovaBay’s DERMADoctor Calm Cool + Corrected clinical repair balm has received the National Eczema Association Seal of Acceptance and is part of the company’s portfolio of specialized products targeting wound care, ophthalmology and dermatology.

QVC’s DERMADoctor segment can be accessed on the QVC website.

Share this article:

Share This Article

 

About the Author

NovaBay’s DERMADoctors Products Introduced to Millions of Households in QVC® Placement

Editor Prism MarketView